Impact of Endocrine Therapy Timing on Disease-Free Survival in Breast Cancer: Insights from the UNIRAD Phase III Trial

Abstract Background: Circadian rhythms regulate cellular physiology and could influence the efficacy of endocrine therapy (ET) in breast cancer (BC). We prospectively tested this hypothesis within the UNIRAD adjuvant phase III trial (NCT01805271). Me...